ALKERMES reported $166.3M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
Amgen AMGN:US USD 4.93B 173M
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Coherus Biosciences CHRS:US USD 27.72M 4.02M
Gilead Sciences GILD:US USD 2.82B 218M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Horizon Pharma HZNP:US USD 190.26M 13.42M
Intra Cellular Therapies ITCI:US USD 23.6M 1.42M
IONIS PHARMACEUT IONS:US USD 20.64M 834K
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Otsuka Holdings 4578:JP JPY 229.26B 11.57B
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Revance Therapeutics RVNC:US USD 17.18M 3.58M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M